Matthew M. Bennett's most recent trade in Bellerophon Therapeutics Inc was a trade of 6,509 Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 10, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics Inc | Matthew M. Bennett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2020 | 6,509 | 6,509 | - | - | Stock Option (right to buy) |